Skip to content

Lilly

Login|Contact us|Worldwide|Sitemap|

  • Home
  • About Us
  • Responsibility
  • Products
  • Research & Development
  • Investors
  • Careers
  • News
Home > News > Media Kits

Media Kits

  • News
  • Corporate News
  • Financial News
  • Product News
  • Speeches
  • Media Contacts
  • Press Release Archives
  • Media Kits
    • Alimta®
    • Byetta®
    • Bone and Osteoporosis Information
    • Cialis®
    • Cymbalta®
    • Gemzar®
    • Global Day of Service
    • Healthy You
    • Health Care Disparities
    • Medicaid Partnerships
    • Multiple Drug Resistant Tuberculosis
    • Strattera®
    • Symbyax™
    • Xigris®
    • Zyprexa®
  • Photos
    • Logos
    • Locations
    • People
    • Products
  • Helpful Links
  • Alimta® (pemetrexed)
  • Byetta® (exenatide) injection
  • Bone and Osteoporosis Information
  • Cialis® (tadalafil)
  • Cymbalta® (duloxetine hydrocholoride)
  • Gemzar® (gemcitabine hydrochloride)
  • Global Day of Service
  • Healthy You
  • Health Care Disparities
  • Medicaid Partnerships
  • Multiple Drug Resistant Tuberculosis (MDR-TB)
  • Strattera® (atomoxetine hydrochloride)
  • Symbyax™ (olanzapine and fluoxetine hydrochloride)
  • The Lilly TB Drug Discovery Initiative
  • Xigris® (drotrecogin alfa [activated])
  • Zyprexa® (olanzapine) Products

Copyright © Eli Lilly and Company. All rights reserved.

Careers | Terms of Use | Privacy | For Suppliers | Sitemap | Contact us